Farzad Nasri

569 total citations · 1 hit paper
13 papers, 388 citations indexed

About

Farzad Nasri is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Farzad Nasri has authored 13 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Farzad Nasri's work include Immunotherapy and Immune Responses (2 papers), Galectins and Cancer Biology (2 papers) and Energy, Environment, Economic Growth (1 paper). Farzad Nasri is often cited by papers focused on Immunotherapy and Immune Responses (2 papers), Galectins and Cancer Biology (2 papers) and Energy, Environment, Economic Growth (1 paper). Farzad Nasri collaborates with scholars based in Iran, Netherlands and France. Farzad Nasri's co-authors include Pouria Khani, Reza Falak, Reza Zolfaghari Emameh, Johan Garssen, Asieh Hosseini, Hamed Mirzaei, Javid Sadri Nahand, Ali Zekri, Mohammad Reza Bolouri and Farideh Ghazi and has published in prestigious journals such as Journal of Neurochemistry, Journal of Cellular Physiology and Cancer Immunology Immunotherapy.

In The Last Decade

Farzad Nasri

11 papers receiving 383 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemotherapy: a double-edged sword in cancer treatment

2021 235 citations Farzad Nasri, Reza Zolfaghari Emameh et al. Cancer Immunology Immunotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Farzad Nasri Iran	6	169	96	93	72	64	13	388
Pouria Khani Iran	7	173 1.0×	92 1.0×	94 1.0×	72 1.0×	62 1.0×	13	386
Mahsa Akbari Oryani Iran	12	215 1.3×	129 1.3×	73 0.8×	101 1.4×	77 1.2×	28	518
Chang‐Chun Ling China	12	235 1.4×	108 1.1×	96 1.0×	66 0.9×	90 1.4×	24	530
Jingwen Huang China	9	191 1.1×	107 1.1×	81 0.9×	108 1.5×	100 1.6×	18	427
Clement Penny South Africa	15	238 1.4×	67 0.7×	103 1.1×	101 1.4×	77 1.2×	52	528
Arul Goel United States	7	237 1.4×	72 0.8×	88 0.9×	87 1.2×	56 0.9×	13	438
Charles H. Adelmann United States	9	309 1.8×	67 0.7×	64 0.7×	78 1.1×	55 0.9×	13	472
Guang Zhu China	14	261 1.5×	137 1.4×	113 1.2×	68 0.9×	92 1.4×	22	509
Simon Heine Germany	9	223 1.3×	117 1.2×	69 0.7×	96 1.3×	72 1.1×	13	513
Hanbing Zou China	15	297 1.8×	123 1.3×	105 1.1×	77 1.1×	86 1.3×	21	572

Countries citing papers authored by Farzad Nasri

Since Specialization

Citations

This map shows the geographic impact of Farzad Nasri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzad Nasri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzad Nasri more than expected).

Fields of papers citing papers by Farzad Nasri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzad Nasri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzad Nasri. The network helps show where Farzad Nasri may publish in the future.

Co-authorship network of co-authors of Farzad Nasri

This figure shows the co-authorship network connecting the top 25 collaborators of Farzad Nasri. A scholar is included among the top collaborators of Farzad Nasri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzad Nasri. Farzad Nasri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Khani, Pouria, et al.. (2025). Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword. Cancer Cell International. 25(1). 117–117. 4 indexed citations

2.

Nasri, Farzad, et al.. (2025). Galectin-9 induces IL-1β production as a key inflammatory cytokine in the acute myeloid leukemia cell line (U937). Research in Pharmaceutical Sciences. 20(2). 304–315. 1 indexed citations

3.

Khani, Pouria, et al.. (2024). mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy. Biomarker Research. 12(1). 157–157. 11 indexed citations

4.

Nasri, Farzad, et al.. (2024). US Funds’ returns-based ESG extraction and implementation: a multifaceted quantile regression approach. Journal of Sustainable Finance & Investment. 15(1). 205–233.

5.

Khani, Pouria, et al.. (2023). Genetic and epigenetic effects on couple adjustment in context of romantic relationship: A scoping systematic review. Frontiers in Genetics. 14. 1002048–1002048.

6.

Nasri, Farzad, Reza Zolfaghari Emameh, Pouria Khani, et al.. (2021). Chemotherapy: a double-edged sword in cancer treatment. Cancer Immunology Immunotherapy. 71(3). 507–526. 235 indexed citations breakdown →

7.

Nasri, Farzad, et al.. (2020). Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin. Iranian Journal of Allergy Asthma and Immunology. 19(6). 602–611. 9 indexed citations

8.

Fallahpour, Morteza, Mohammad Reza Bolouri, Reza Mahmoudi, et al.. (2020). Evaluating the Immunoreactivity of Ailanthus Altissima (the Tree of Heaven) Pollen Extract in Atopic Patients. Iranian Journal of Allergy Asthma and Immunology. 19(2). 132–138. 5 indexed citations

9.

Kardar, Gholam Ali, et al.. (2020). Overexpression of bHLH domain of HIF-1 failed to inhibit the HIF-1 transcriptional activity in hypoxia. Biological Research. 53(1). 25–25. 11 indexed citations

10.

Khani, Pouria, et al.. (2018). Genetic and epigenetic contribution to astrocytic gliomas pathogenesis. Journal of Neurochemistry. 148(2). 188–203. 84 indexed citations

11.

Khani, Pouria, Farideh Ghazi, Ali Zekri, et al.. (2018). Keratins and epidermolysis bullosa simplex. Journal of Cellular Physiology. 234(1). 289–297. 20 indexed citations

12.

Saaidpour, Saadi, Seyed Amir Zarei, & Farzad Nasri. (2012). QSPR study of molar diamagnetic susceptibility of diverse organic compounds using multiple linear regression analysis. 2(1). 6–17. 3 indexed citations

13.

Tranchand, Brigitte, C Ardiet, Éric Bouffet, et al.. (1994). [Effect of carboplatin on the pharmacokinetics of melphalan administered intravenously].. PubMed. 81(1). 43–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact